Evidence map›Paper›PMID 38794134›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Comprehensive Analysis of Drug Utilization Patterns, Gender Disparities, Lifestyle Influences, and Genetic Factors: Insights from Elderly Cohort Using g-Nomic

Bárbara Rodríguez Castillo, Marc Cendrós, Carlos J Ciudad, Ana Sabater

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bárbara Rodríguez CastilloDepartment of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universidad de Barcelona, 08007 Barcelona, Spain.
Marc CendrósTechnical Department, Eugenomic, 08029 Barcelona, Spain.
Carlos J CiudadDepartment of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universidad de Barcelona, 08007 Barcelona, Spain.ORCID 0000-0002-7855-392X
Ana SabaterTechnical Department, Eugenomic, 08029 Barcelona, Spain.ORCID 0000-0002-5359-4995

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polypharmacy is a global healthcare concern, especially among the elderly, leading to drug interactions and adverse reactions, which are significant causes of death in developed nations. However, the integration of pharmacogenetics can help mitigate these risks. In this study, the data from 483 patients, primarily elderly and polymedicated, were analyzed using Eugenomic

Indexed as

antihypertensivecholesteroldrug adverse reactionsgastroprotectivegenderg-Nomic®lifestylepharmacogeneticsplatelet aggregationpolypharmacy

Identifiers

PMID38794134
PMCPMC11123674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.